Related Experiment Videos
Statin myopathy: a common dilemma not reflected in clinical trials
Genaro Fernandez1, Erica S Spatz, Charles Jablecki
1Internal Medicine Residency Program,The University of Utah, Salt Lake City, Utah, USA.
Abstract:
Although statins are remarkably effective, they are still underprescribed because of concerns about muscle toxicity. We review the aspects of statin myopathy that are important to the primary care physician and provide a guide for evaluating patients on statins who present with muscle complaints. We outline the differential diagnosis, the risks and benefits of statin therapy in patients with possible toxicity, and the subsequent treatment options.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Atherosclerosis III: Management
Myocarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence